Datasets:
sruthiselvakumar
/
dataset

Dataset card Data Studio Files
xet
 Community
text
stringlengths
0
146
specialist.
Carcinoma in situ of
Specified Organs treated
with Radical Surgery
The actual undergoing of a
Radical Surgery to arrest
the
spread of malignancy in
that specific organ, which
must be considered as
appropriate and necessary
treatment.
“Radical Surgery” is
defined in this policy as
the total and complete
removal of one (1) of the
following organs: breast
(mastectomy), prostate
(prostatectomy), corpus
uteri (hysterectomy), ovary
(oopherectomy), fallopian
tube (salpingectomy),
colon (partial colectomy
with end to end
anastomosis) or stomach
(partial gastrectomy with
end to end anastomosis).
The diagnosis of the
Carcinoma in situ must
always be positively
Major Burns
Third degree (full
thickness of the skin)
burns covering at least
20% of the surface of the
life insured’s body.
Major Cancer
A malignant tumour
positively diagnosed with
histological confirmation
and characterized by the
uncontrolled growth of
malignant cells with
invasion and destruction of
normal tissue.
The term Major Cancer
includes, but is not limited
to, leukemia, lymphoma
and sarcoma.
Major Cancer diagnosed
on the basis of finding
tumour cells and/or
tumour-associated
molecules in blood, saliva,
faeces, urine or any other
bodily fluid in the absence
of further definitive and
clinically verifiable
evidence does not meet
the above definition.
For the above definition,
the following are excluded:
Manulife CI FlexiCare (Deluxe) v0123
Page 22 of 42
Manulife (Singapore) Pte. Ltd.
A Manulife Company
Conditions
Early Stage
Prostate cancer that is
histologically described
using the TNM
Classification as T1N0M0
or Prostate cancers
described using another
equivalent classification.
Early Thyroid Cancer
Thyroid cancer that is
histologically described
using the TNM
Classification as T1N0M0
as well as Papillary
microcarcinoma of thyroid.
Early Bladder Cancer
Bladder cancer that is
histologically described
using the TNM
Classification as Tis or
T1N0M0. Non-invasive
papillary urothelial
carcinoma of the bladder
(stage Ta) is excluded.
Early Chronic
Lymphocytic Leukemia
Chronic Lymphocytic